The Ophthalmologist Assembles Expert Panel to Discuss Glaucoma Patient Care in a Pandemic

New York, U.S.A., April 8, 2021 – Missed appointments, delayed prescriptions, disease progression, the need for surgical intervention: this is the real-life impact of the COVID-19 pandemic on glaucoma patients, according to a leading, global panel of experts in a recent roundtable meeting with The Ophthalmologist. And while the ramifications, coupled with those resulting from the delayed training of residents and fellows, will be felt beyond the immediate term, glaucoma doctors have found a silver lining during this challenging time. The creative solutions that they quickly implemented to manage their patients, will likely support the sustainable delivery of good glaucoma patient care well into the future.

Aleksandra Jones, Editor of The Ophthalmologist, says, “Having heard many glaucoma specialists worldwide express great concern over their patients’ care throughout the pandemic, with appointments canceled or postponed and elderly patients avoiding routine visits, I invited four leading experts from four different countries to talk about how they are addressing these challenges. This resulted in an incredibly insightful conversation around risk stratification, virtual visits, remote IOP monitoring, and surgical solutions that every glaucoma specialist, fellow, or resident should watch.”

Recorded in March 2021, the roundtable discussion “Glaucoma and the Pandemic: A Surgery-Led Approach” is available to watch here. 

The expert panel included:

• Miriam Kolko, Professor in Translational Eye Research at the University of Copenhagen and Chief Physician at the Copenhagen University Hospital, Denmark, who moderated the discussion.
• Constance Okeke, Glaucoma & Cataract Specialist CVP Physicians at Virginia Eye Consultants, Assistant Professor of Ophthalmology, Eastern Virginia Medical School, Norfolk, Virginia, U.S.A.
• Kaweh Mansouri, Consultant Ophthalmologist at the Glaucoma Center, Montchoisi Clinic, Switzerland and Department of Ophthalmology, University of Colorado, Denver, U.S.A.

• Anthony Khawaja, Consultant Ophthalmologist at Moorfields Eye Hospital, UCL Institute of Ophthalmology, London, U.K.

The roundtable was sponsored by Headline Sponsor, Allergan, and Supporting Sponsor, Nova Eye Medical, and is available to view at no charge.